Literature DB >> 22735955

Transient expression technologies: past, present, and future.

Sabine Geisse1, Bernd Voedisch.   

Abstract

The first protocols describing transient gene expression in mammalian cells for the rapid generation of recombinant proteins emerged more than 10 years ago as an alternative to the establishment of stable, often amplified clonal cell lines, and relieved somewhat the bias against mammalian cell systems as being too complicated, labor intensive, and tedious to serve as a source for tool proteins in industrial research and academia. Over the past decade, these attempts have been refined and optimized, giving rise to expression protocols applicable in every lab in dependence on available tools, equipment, and envisaged outcome. This chapter summarizes the development of transient expression technologies over the past decade up to its current status and provides an outlook into what may be the future of transient technology development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22735955     DOI: 10.1007/978-1-61779-921-1_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  Recent advances in mammalian protein production.

Authors:  Ashok D Bandaranayake; Steven C Almo
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

2.  A novel luminescence-based method for the detection of functionally active antibodies to muscarinic acetylcholine receptors of the M3 type (mAchR3) in patients' sera.

Authors:  B Preuss; S Tunaru; J Henes; S Offermanns; R Klein
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

3.  Heterologous expression of plant glycosyltransferases for biochemistry and structural biology.

Authors:  Pradeep K Prabhakar; Hsin-Tzu Wang; Peter J Smith; Jeong-Yeh Yang; William J Barnes; Maria J Peña; Kelley W Moremen; Breeanna R Urbanowicz
Journal:  Methods Cell Biol       Date:  2020-06-13       Impact factor: 1.441

4.  Unexpected transcellular protein crossover occurs during canonical DNA transfection.

Authors:  Jason Arsenault; Sabine A G Cuijpers; Dhevahi Niranjan; Bazbek Davletov
Journal:  J Cell Biochem       Date:  2014-12       Impact factor: 4.429

5.  XBP1 mitigates aminoglycoside-induced endoplasmic reticulum stress and neuronal cell death.

Authors:  N Oishi; S Duscha; H Boukari; M Meyer; J Xie; G Wei; T Schrepfer; B Roschitzki; E C Boettger; J Schacht
Journal:  Cell Death Dis       Date:  2015-05-14       Impact factor: 8.469

6.  Immunogenomic engineering of a plug-and-(dis)play hybridoma platform.

Authors:  Mark Pogson; Cristina Parola; William J Kelton; Paul Heuberger; Sai T Reddy
Journal:  Nat Commun       Date:  2016-08-17       Impact factor: 14.919

Review 7.  Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.

Authors:  Hilal Ahmed Parray; Shivangi Shukla; Sweety Samal; Tripti Shrivastava; Shubbir Ahmed; Chandresh Sharma; Rajesh Kumar
Journal:  Int Immunopharmacol       Date:  2020-05-27       Impact factor: 4.932

8.  Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment.

Authors:  Matthieu Chodorge; Anthony J Celeste; Joseph Grimsby; Anish Konkar; Pia Davidsson; David Fairman; Lesley Jenkinson; Jacqueline Naylor; Nicholas White; Jonathan C Seaman; Karen Dickson; Benjamin Kemp; Jennifer Spooner; Emmanuel Rossy; David C Hornigold; James L Trevaskis; Nicholas J Bond; Timothy B London; Andrew Buchanan; Tristan Vaughan; Cristina M Rondinone; Jane K Osbourn
Journal:  Sci Rep       Date:  2018-12-03       Impact factor: 4.379

9.  Recombinant production, purification, crystallization, and structure analysis of human transforming growth factor β2 in a new conformation.

Authors:  Laura Del Amo-Maestro; Laura Marino-Puertas; Theodoros Goulas; F Xavier Gomis-Rüth
Journal:  Sci Rep       Date:  2019-06-17       Impact factor: 4.379

10.  Transfected HEK293 cells expressing functional recombinant intercellular adhesion molecule 1 (ICAM-1)--a receptor associated with severe Plasmodium falciparum malaria.

Authors:  Anja Bengtsson; Louise Joergensen; Zachary R Barbati; Alister Craig; Lars Hviid; Anja T R Jensen
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.